导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 59.92% | 31/1050 |
| 近一周 | 2.58% | 73/1104 |
| 近一月 | 0.57% | 99/1103 |
| 近一季 | -11.30% | 759/1092 |
| 近半年 | 52.04% | 18/1070 |
| 近一年 | 72.56% | 31/1018 |
| 近两年 | 261.12% | 34/926 |
| 近三年 | 180.74% | 44/834 |
| 成立以来 | 300.35% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.93% 553/1070 |
105.90% 25/1101 |
- - |
- - |
| 2025 | 87.96% 25/1065 |
-1.91% 906/1014 |
5.59% 266/1038 |
72.66% 8/1050 |
5.11% 135/1065 |
| 2024 | -2.04% 637/1011 |
-6.39% 633/960 |
0.16% 297/983 |
4.27% 902/991 |
0.20% 308/1011 |
| 2023 | -13.51% 456/952 |
11.86% 87/880 |
10.58% 18/895 |
-25.05% 885/915 |
-6.70% 648/952 |
| 2022 | -29.47% 615/867 |
-25.62% 722/773 |
9.16% 294/806 |
-0.24% 16/845 |
-12.92% 821/867 |
| 2021 | 52.48% 12/740 |
-6.75% 410/580 |
37.51% 21/659 |
10.62% 56/704 |
7.49% 134/740 |
| 2020 | 62.69% 178/554 |
7.53% 52/419 |
36.54% 52/466 |
-0.52% 426/517 |
11.39% 314/554 |
| 2019 | 39.48% 225/410 |
16.93% 974/1146 |
-5.97% 774/1228 |
14.42% 44/390 |
10.86% 139/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8665 | 61.36% |
| 招商前沿医疗保健股票C | 0.8313 | 61.04% |
| 招商医药健康产业股票 | 2.7000 | 53.78% |
| 前海开源公共卫生股票A | 0.4844 | 46.12% |
| 广发医药精选股票A | 1.3562 | 44.63% |
| 嘉实医疗保健股票 | 2.6570 | 42.34% |
| 前海开源公共卫生股票C | 0.4741 | 42.24% |
| 广发医药精选股票C | 1.3346 | 40.86% |
| 交银医药创新股票A | 2.9498 | 37.46% |
| 交银医药创新股票C | 3.1324 | 37.26% |
| 海富通电子传媒股票A VS. 东吴新产业精选股票A(580008) |